Repositioning Candidate Details

Candidate ID: R0500
Source ID: DB01349
Source Type: experimental
Compound Type: small molecule
Compound Name: Tasosartan
Synonyms: Tasosartan
Molecular Formula: C23H21N7O
SMILES: CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1
Structure:
DrugBank Description: Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertension.
CAS Number: 145733-36-4
Molecular Weight: 411.4591
DrugBank Indication: Tasosartan is infrequently in the treatment of hypertension and heart failure.
DrugBank Pharmacology: By blocking the angiotensin II (AT1) receptor, the drug ultimately causes vasodilation, reduced secretion of vasopressin (ADH), reduced production and secretion of aldosterone, amongst other actions leading to the combined effect of a reduction of blood pressure.
DrugBank MoA: Tasosartan is a selective, potent, orally active and long-acting nonpeptide Angiotensin II type 1 (AT1) receptor antagonist. Tasosartan blocks the renin-angiotensin-aldosterone system (RAAS) at the level of the AT1 receptor that mediates most, if not all, of the important actions of Ang II. Tasosartan binds reversibly to the AT1 receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. AT1 receptor antagonists avoid the nonspecificity of the Ang I converting enzyme (ACE) inhibitors.
Targets: Type-1 angiotensin II receptor antagonist; Type-2 angiotensin II receptor antagonist
Inclusion Criteria: Target associated